Billionaire Bill Ackman Invests $400 Million in Brain Research After Daughter's Stroke

Hedge fund manager Bill Ackman is launching a global research center focused on brain repair and longevity, backed by an unprecedented $400 million investment. This initiative follows a severe brain hemorrhage suffered by his 26-year-old daughter, Lucy, in February. The hemorrhage caused her to experience paralysis, blindness, and loss of speech.

In an attempt to restore her vision, doctors received emergency FDA approval for an experimental treatment involving the transplantation of mitochondria, the "powerhouses" of cells, taken from Lucy's leg muscle and injected directly into her eyes. Early results showed a temporary improvement, with Lucy regaining the ability to detect light, though the effect lasted only about a month. The medical team is now working on increasing the frequency of these injections.

The experimental therapy has generated both interest and skepticism among scientists regarding the efficacy of such small doses in a complex system. Ackman, alongside his Israeli wife Neri Oxman, has established the Ackman-Oxman Center (AOI) with the goal of becoming a world leader in brain repair and life extension. The center's board includes a Nobel laureate, leading neuroscientists, and the CEO of Regeneron Pharmaceuticals.

Ackman's move aligns with a broader trend of wealthy American tech elites investing heavily in private research for longevity and brain-computer interfaces, particularly amid cuts to federal research grants. He noted that the academic turmoil surrounding politics and antisemitism on university campuses allowed him to acquire real estate and recruit top researchers disillusioned with the institutional system. The new institute aims to develop practical, rapid treatments for patients rather than focusing solely on theoretical publications.